Saffron: forms and safety
Saffron spice and extracts, safety limitations and rivaroxaban.
Key points
- Culinary saffron is the dried stigmas of Crocus sativus; the spice and standardized extract differ in composition. The mass of spice does not establish the dose of the extract studied. [1] [2] [3] See the evidence 1 2
- The safety of concentrated saffron supplements during pregnancy and breastfeeding and in children has not been established; a case of bleeding with rivaroxaban has been described with unknown causation. Discuss such a supplement with a clinician before taking it. [4] [5] See the evidence 1 2
Practical guide
Check the conclusions and whether they apply to your situation.
Culinary saffron and concentrated supplements differ in composition.
Key points
Why these conclusions
Forms and safety
Saffron is the dried stigmas of Crocus sativus. The spice, standardized Safr’Inside extract and individual saffron compounds differ in composition; the RCT result concerns the extract studied. [1] [2]
One teaspoon of dried saffron stigmas contains approximately 0.7 g of spice and 2.17 kcal. These data do not establish the amount of crocin or extract. [3]
Gastrointestinal adverse events, usually mild, have been reported in saffron studies; not all studies collected them systematically. [5]
Safety data for concentrated saffron supplements during pregnancy and breastfeeding and in children are insufficient; food use of the spice is considered separately. [4] [5]
Rivaroxaban: In one reported case, bleeding occurred when rivaroxaban was combined with a saffron supplement; causation and frequency are unknown. Before taking a saffron supplement, discuss it with the clinician who prescribed the anticoagulant. [5]
Short-term saffron supplement studies cannot establish rare or long-term risks. [5]
The sleep study used standardized Safr’Inside at 20 or 30 mg daily for four weeks; the mood study used Activ’Inside at 15 mg twice daily for six weeks. These durations and doses concern the specified extracts. [2] [6]
Saffron is the dried stigmas of Crocus sativus. The spice, standardized Safr’Inside extract and individual saffron compounds differ in composition; the RCT result concerns the extract studied.
Saffron is the dried stigmas of Crocus sativus. The spice, standardized Safr’Inside extract and individual saffron compounds differ in composition; the RCT result concerns the extract studied. [1] [2]
One teaspoon of dried saffron stigmas contains approximately 0.7 g of spice and 2.17 kcal. These data do not establish the amount of crocin or extract.
| Food | Preparation | Content | Content unit | Basis, g | Portion, g | Content per serving | Energy per serving, kcal | Energy per 100 g, kcal | Sources |
|---|---|---|---|---|---|---|---|---|---|
| Saffron | dried stigmas of Crocus sativus | 100 | g dried saffron (spice mass) | 100 | 0.7 | 0.7 | 2.17 | 310 | [3] |
Gastrointestinal adverse events, usually mild, have been reported in saffron studies; not all studies collected them systematically.
Gastrointestinal adverse events, usually mild, have been reported in saffron studies; not all studies collected them systematically. [5]
Safety data for concentrated saffron supplements during pregnancy and breastfeeding and in children are insufficient; food use of the spice is considered separately.
Safety data for concentrated saffron supplements during pregnancy and breastfeeding and in children are insufficient; food use of the spice is considered separately. [4] [5]
Rivaroxaban: In one reported case, bleeding occurred when rivaroxaban was combined with a saffron supplement; causation and frequency are unknown. Before taking a saffron supplement, discuss it with the clinician who prescribed the anticoagulant.
Rivaroxaban: In one reported case, bleeding occurred when rivaroxaban was combined with a saffron supplement; causation and frequency are unknown. Before taking a saffron supplement, discuss it with the clinician who prescribed the anticoagulant. [5]
Short-term saffron supplement studies cannot establish rare or long-term risks.
Short-term saffron supplement studies cannot establish rare or long-term risks. [5]
After four weeks, AIS sleep symptoms decreased by 0.95 points more than with placebo when the 20 and 30 mg/day Safr’Inside groups were pooled.
| Parameter | Data |
|---|---|
| Result | After four weeks, AIS sleep symptoms decreased by 0.95 points more than with placebo when the 20 and 30 mg/day Safr’Inside groups were pooled. Adjusted AIS difference for pooled 20 and 30 mg versus placebo −0.95 points (95% CI −1.79…−0.11), p=0.027; mean changes −1.54 and −1.96 versus −0.71. |
| Participants | 165 adults with moderate insomnia symptoms, 150 completed |
| Form | Standardized Safr’Inside extract orally about one hour before bedtime |
| Dose | 20 or 30 mg/day, pooled active groups |
| Dose basis | 20 or 30 mg/day, pooled active groups |
| Comparator | Maltodextrin |
| Duration | 4 weeks |
| Confidence | 2/4: Precision: short follow-up and uncertain clinical importance of the size of the change.; Consistency: no grounds for a separate downgrade.; Applicability to the specified group: the measure directly addresses the stated narrow research question.; Possible publication bias: no specific data for a separate downgrade.; Study methods: subjective outcomes, losses and secondary comparisons. |
| Evidence base | 1 trial |
| Sources | [2] |
Activ’Inside showed no advantage over placebo in the composite measure of low mood, anxiety and fatigue or its individual components.
| Parameter | Data |
|---|---|
| Result | Activ’Inside showed no advantage over placebo in the composite measure of low mood, anxiety and fatigue or its individual components. No significant between-group difference was shown for the composite or its individual components. |
| Participants | 51 adults with subclinical depressive symptoms |
| Form | Activ’Inside extract, >2.5% crocins and >1.5% safranal using the specified different analytical methods |
| Dose | 15 mg twice daily with breakfast and dinner |
| Dose basis | 15 mg twice daily with breakfast and dinner |
| Comparator | Maltodextrin |
| Duration | 6 weeks |
| Confidence | 2/4: risk_of_bias: multiple outcomes and self-ratings.; inconsistency: no grounds for a separate downgrade.; indirectness: the measure directly addresses the specified narrow PICO.; imprecision: 51 participants; exact CI of the comparative effect not confirmed.; publication_bias: no specific data for a separate downgrade. |
| Evidence base | 1 trial |
| Sources | [6] |
More details
When to discuss a supplement
If taking rivaroxaban, discuss a saffron supplement with the clinician who prescribed the anticoagulant; causation in the reported bleeding case has not been established. [5]
Sources
- CPG Sec 525.750 Spices - Definitions. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cpg-sec-525750-spices-definitions
- Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial. https://pmc.ncbi.nlm.nih.gov/articles/PMC12281372/
- USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 02. https://www.ars.usda.gov/ARSUserFiles/80400535/Data/SR/SR28/reports/sr28fg02.pdf
- Saffron and Pregnancy: Cultural Practices, Beliefs, and Safety Evidence: An Integrative Review. https://pubmed.ncbi.nlm.nih.gov/42186868/
- Adverse Events of Saffron (Crocus sativus L.): Systematic Review of Current Evidence. https://pubmed.ncbi.nlm.nih.gov/42057871/
- Effect of saffron extract supplementation on mood in healthy adults with subclinical symptoms of depression: a randomized, double-blind placebo-controlled study.. https://pubmed.ncbi.nlm.nih.gov/41047129/
Methodology: Subpages evidence-led supplement pipeline v1